Edition:
United Kingdom

Cipla Ltd (CIPL.NS)

CIPL.NS on National Stock Exchange of India

603.45INR
10:17am GMT
Change (% chg)

Rs3.05 (+0.51%)
Prev Close
Rs600.40
Open
Rs603.45
Day's High
Rs606.10
Day's Low
Rs592.00
Volume
1,599,249
Avg. Vol
1,514,125
52-wk High
Rs663.40
52-wk Low
Rs480.20

Select another date:

Thu, Feb 8 2018

Indian shares gain over 1 pct after 7 days of falls

Feb 8 Indian shares rose more than 1 percent on Thursday after seven consecutive sessions of declines, as market heavyweights such as Infosys recovered and as drug maker Cipla gained on solid earnings.

UPDATE 1-India's Cipla Q3 profit rises, but below estimates

Feb 7 Cipla Ltd, India's fourth-largest drugmaker by revenue, said third-quarter net profit rose 7 percent on strong domestic sales, but fell short of analysts' estimates.

BRIEF-Cipla Says Key Performance Metrics Inline With Co's Internal Targets

* SAYS KEY PERFORMANCE METRICS LOOK HEALTHY AND ARE INLINE WITH CO'S INTERNAL TARGETS Source text - http://bit.ly/2BhN3M6 Further company coverage:

India's Cipla Q3 profit rises about 7 pct

Feb 7 Cipla Ltd, India's fourth-largest drugmaker by revenue, posted an about 7 percent rise in third-quarter net profit on Wednesday, but missed analysts' estimates.

BRIEF-India's Cipla Dec-Qtr Consol Profit Up 7 Pct

* DEC QUARTER CONSOL NET PROFIT 4.01 BILLION RUPEES VERSUS PROFIT OF 3.75 BILLION RUPEES LAST YEAR

BRIEF-India's Cipla Gets U.S. FDA Nod For Generic Viread Tablets

* GETS ANDA FOR TENOFOVIR DISOPROXIL FUMARATE TABLETS FROM U.S. FDA Source text - http://bit.ly/2DW6lbS Further company coverage:

BRIEF-Kiadis Pharma Proposes Subhanu Saxena, Former Cipla CEO, As New Supervisory Board Member

* KIADIS PHARMA PROPOSES FORMER CIPLA CEO SUBHANU SAXENA AS NEW SUPERVISORY BOARD MEMBER

BRIEF-Cipla Launches Q-Tib Globally

* SAYS GOT APPROVAL FOR PRODUCT Q-TIB FROM WORLD HEALTH ORGANISATION

BRIEF-Cipla gets final approval for generic Dacogen​

* Drug indicated for treatment of patients with myelodysplastic syndromes

Yes Bank, IndusInd to join India's BSE Sensex index; Lupin, Cipla dropped

Nov 17 Indian private sector lenders Yes Bank Ltd and IndusInd Bank Ltd will join the BSE stock exchange's 30-member Sensex index, effective Dec. 18, the index provider said on Friday.

Select another date: